Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Am J Med. 2020 Jan 23;133(6):741–749. doi: 10.1016/j.amjmed.2019.12.025

Table 3.

Smoking Cessation After Hospital Discharge

Smoking Cessation* Enhanced Usual Care Group (N=92) Financial Incentive Group (N=90) P Value

n/N Percent n/N Percent
Smoking cessation at 2 weeks (%)
 Self-reported 27/67 40.3 35/75 46.7 0.445
Smoking cessation at 2 months (%)
 Self-reported 24/65 36.9 40/68 58.8 0.012
 Bioconfirmed 12/48 25.0 14/40 35.0 0.306
 No saliva sample submitted 7/24 29.2 16/40 40.0 0.382
 Positive saliva sample submitted 5/24 20.8 10/40 25.0 0.703
Smoking cessation at 6 months (%)
 Self-reported 26/70 37.1 35/64 54.7 0.042
 Bioconfirmed 5/56 8.9 9/46 19.6 0.103
 No saliva sample submitted 5/26 19.2 8/35 22.9 0.732
 Positive saliva sample submitted 16/26 61.5 18/35 51.4 0.432
*

The denominator for self-reported smoking cessation indicates the number of participants who completed follow-up at each time point. The denominator for bioconfirmation indicates the number of participants who submitted a saliva sample or provided expired CO

Among participants with self-reported smoking cessation

P value for bioconfirmed smoking cessation at 6 months based on logistic regression model with multiple imputation for missing smoking cessation values

Note: At 6 months, 72 patients in the enhanced usual care group and 65 patients in the financial incentive group participated in the phone survey. Of these patients, 2 patients in the enhanced usual care group and 1 patient in the financial incentive group did not respond to questions about current smoking. After the 6 month phone survey, 56 patients in the enhanced usual care group and 46 patients in the financial incentive group subsequently presented for bioconfirmation.